Free Trial
→ “The crisis that’s emerging now is just the tip of the iceberg,” says Dr. Martin D. Weiss, who has made shocking and accurate predictions for 55 years (From Weiss Ratings) (Ad)tc pixel
NASDAQ:RCEL

Avita Medical Q3 2026 Earnings Date & Estimates

Avita Medical logo
$13.04 -0.37 (-2.76%)
Closing price 10/16/2026 04:00 PM Eastern
Extended Trading
$13.20 +0.16 (+1.23%)
As of 10/16/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Avita Medical is estimated to report Q3 2026 earnings on Thursday, November 5, 2026, after market closes. The conference call is scheduled for 4:30 PM ET.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
After Market Closes
Conference Call
4:30 PM ET
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Avita Medical in Q3 2026

Avita Medical is expected to post earnings of -$0.2394 per share on revenue of $22.35 million. In the same quarter a year earlier Avita Medical reported -$0.46 per share on revenue of $17.06 million. Avita Medical last reported on August 6, 2026, posting -$0.25 per share and beating the -$0.2928 consensus estimate. Avita Medical has beaten the consensus EPS estimate in 1 of its last 8 quarters.

Consensus Estimates

Consensus EPS
-$0.2394
Expected Revenue
$22.35 million
Prior-Year EPS
-$0.46
Prior-Year Revenue
$17.06 million
Expected Revenue Growth
+31.0%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
-$0.25 (Beat by +$0.0428)
Last Quarter Revenue
$21.70 million
EPS Beat Rate
1 of last 8 quarters

Prepare for the Q3 2026 Call

Avita Medical Q3 2026 Earnings FAQ

Avita Medical (NASDAQ:RCEL) is estimated to report Q3 2026 earnings on Thursday, November 5, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it.

Avita Medical's Q3 2026 earnings conference call is scheduled for Thursday, November 5, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Avita Medical to post earnings of -$0.2394 per share for Q3 2026.

The consensus revenue estimate for Avita Medical is $22.35 million for Q3 2026.

Avita Medical Earnings Headlines

Organigram Global (NASDAQ:OGI) & Avita Medical (NASDAQ:RCEL) Critical Review
October 14, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31118426
Avita Medical (NASDAQ:RCEL) Stock Price Expected to Rise, BTIG Research Analyst Says
October 12, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31110333
Did you grab your copy yet?
Bill Poulos's Top 10 Stocks to Buy This Quarter report is still available free, but not for long. Every quarter he swaps in a brand-new list, and once the new edition launches, this one disappears. Investors who want a current snapshot of his picks should grab a copy now and save it before the switch happens.tc pixel
October 18 at 1:00 AM  |  Profits Run (Ad)
Avita Medical Inc. (NASDAQ:RCEL) Stock Has Consensus Price Target of $11.40
October 8, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31097874
Avita Medical (NASDAQ:RCEL) vs. Flora Growth (NASDAQ:FLGC) Head-To-Head Contrast
October 7, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31095594
Is AVITA Medical Inc (RCEL) Overvalued After 5.9% Rally? GF Value Says Overvalued
October 3, 2026  |  gurufocus.comhttps://www.gurufocus.com/news/9108386/is-avita-medical-inc-rcel-overvalued-after-59-rally-gf-value-says-overvalued
See More Avita Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Avita Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Avita Medical and other key companies, straight to your email.

About Avita Medical

Avita Medical (NASDAQ:RCEL) is a regenerative medicine company focused on developing and commercializing technologies that use a patient’s own cells to support skin repair and healing. The company’s platform is designed to create a suspension of regenerative cells from a small sample of healthy skin, which can then be applied to damaged areas.

Its primary product is the RECELL Autologous Cell Harvesting Device, a point-of-care system that prepares a patient’s skin cells for use in treating thermal burn wounds. RECELL is intended to help clinicians cover larger wound areas using smaller skin samples and is used in specialized wound-care and burn-treatment settings. The company has also pursued applications of its technology in areas such as repigmentation and other skin-related conditions.

Avita Medical was established from technology developed in Australia and has built its commercial and corporate operations around the United States. Its products are primarily marketed to hospitals, burn centers and other healthcare providers, with the United States serving as its principal commercial market. The company is headquartered in Valencia, California, and its shares trade on the Nasdaq under the symbol RCEL.

View Avita Medical Profile
Earnings Tools